(Q37628645)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

review article

1 reference

title

CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Timothy M Clay

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

361-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11316930-000000000-00000

11 February 2020

exact match

0 references

cites work

In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG.

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

TLR9 is localized in the endoplasmic reticulum prior to stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Protein kinase D1: a new component in TLR9 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Distinct response of human B cell subpopulations in recognition of an innate immune signal, CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Inhibition of coagulation by a phosphorothioate oligonucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Immunostimulatory DNA sequences influence the course of adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11316930-000000000-00000

TLR9 signals after translocating from the ER to CpG DNA in the lysosome

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NI1028

Identifiers

DOI

10.2165/11316930-000000000-00000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19894778%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference